☰

Yang-Xin Fu

Affiliations: 
Immunology University of Chicago, Chicago, IL 
Area:
Immunology, Microbiology Biology
Google:
"Yang-Xin Fu"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Robert K. Chin grad student 2004 Chicago
James C. Lo grad student 2004 Chicago
Sumit K. Subudhi grad student 2004 Chicago
Sarah E. Blink grad student 2006 Chicago
Sogyong L. Auh grad student 2009 Chicago
Mendy L. Miller grad student 2010 Chicago
Jeremy O'Sullivan grad student 2011 Chicago
Byron C. Burnette grad student 2012 Chicago
Tony C. Tu grad student 2013 Chicago
Vaibhav Upadhyay grad student 2013 Chicago

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang J, Li S, Wang M, et al. (2024) STING licensing of type I dendritic cells potentiates antitumor immunity. Science Immunology. 9: eadj3945
Wang J, Li S, Wang M, et al. (2024) STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity. Biorxiv : the Preprint Server For Biology
Wang X, Liu L, Yue T, et al. (2023) Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8 T cells. Signal Transduction and Targeted Therapy. 8: 268
Moore C, Bae J, Liu L, et al. (2022) Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity. Jci Insight. 7
Feng Q, Liu Z, Yu X, et al. (2022) Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nature Communications. 13: 4981
Li F, Zhang H, Wang W, et al. (2022) T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies. Nature Communications. 13: 4334
Lee KM, Lin CC, Servetto A, et al. (2022) Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple negative breast cancer. Cancer Immunology Research
Li H, Liu Z, Liu L, et al. (2022) AXL targeting restores PD-1 blockade sensitivity of mutant NSCLC through expansion of TCF1 CD8 T cells. Cell Reports. Medicine. 3: 100554
Liu L, Chen J, Zhang H, et al. (2022) Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity. Nature Cancer
Xue D, Moon B, Liao J, et al. (2022) A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors. Science Immunology. 7: eabi6899
See more...